IOVA
IOVANCE BIOTHERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$14.21
+4.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 59.26x
- P/S forward
- 11.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.75x
- Price / sales
- 19.81x
- Price / cash flow
- -24.36x
Enterprise value
- Enterprise value
- $6.2B
- EV / sales
- 19.03x
- EV / EBITDA
- -24.62x
- EV / EBIT
- -20.88x
- Market cap
- $6.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026